Although the percentage of proliferating tumor cells (i.e. Ki-67+) did not appear altered, there was noticeably more cell death (i.e. TUNEL+ cells; Figure 1B) and ESA+CD44+ cells were more frequent in tumors from CPA-treated mice (Figure 1D). This evidence concerns the gene EPCAM and neoplasm.